|1.||Herrmann, Nathan: 12 articles (11/2015 - 10/2002)|
|2.||Padovani, Alessandro: 12 articles (01/2014 - 06/2003)|
|3.||Gauthier, Serge: 11 articles (04/2011 - 01/2003)|
|4.||Bullock, Roger: 11 articles (03/2011 - 01/2003)|
|5.||Lanctôt, Krista L: 10 articles (11/2015 - 01/2003)|
|6.||Burns, Alistair: 10 articles (11/2012 - 10/2003)|
|7.||Grossberg, George T: 9 articles (07/2015 - 01/2003)|
|8.||Vellas, Bruno: 9 articles (01/2015 - 01/2004)|
|9.||Greig, Nigel H: 9 articles (01/2014 - 11/2002)|
|10.||Cummings, Jeffrey L: 9 articles (11/2008 - 01/2002)|
|1.||Alzheimer Disease (Alzheimer's Disease)
04/01/2003 - "The most important therapeutic effect of cholinesterase inhibitors (ChEI) on approximately 50% of Alzheimer's disease (AD) patients is to stabilize cognitive function at a steady level during a 1-year period of treatment as compared to placebo. "
01/01/2002 - "Cholinesterase inhibitors have produced the best evidence of clinical efficacy for treating patients with Alzheimer's disease (AD). "
08/01/2006 - "Cholinesterase Inhibitors (ChEIs) have proven efficacy in outpatients with mild to moderate Alzheimer's Disease (AD). "
01/01/2003 - "This huge economic burden is of great interest because of the emergence of several cholinesterase inhibitors with proven efficacy in the treatment of Alzheimer's disease. "
02/01/2001 - "Despite the proven efficacy of acetylcholinesterase inhibitors in Alzheimer's disease, there is a need for new and more effective treatments. "
01/01/2004 - "Observations on the neurochemistry of dementia with Lewy bodies (DLB) have suggested that cholinesterase inhibitors (ChEIs) might be beneficial in treating some clinical symptoms of DLB. "
04/01/2005 - "Recent evidence from small double-blind and open-label trials suggests that cholinesterase inhibitors may be effective in the treatment of dementia associated with PD."
08/01/2004 - "Several small studies with three different cholinesterase inhibitors suggest that these drugs can be effective in the treatment of PD dementia. "
04/01/2003 - "Recent evidence from small studies suggests that cholinesterase inhibitors may be effective in the treatment of dementia associated with PD."
09/01/2007 - "Recent evidence suggests that cholinesterase inhibitors are effective in the treatment of dementia and accompanying behavioral symptoms in PD."
02/01/2009 - "Acetylcholinesterase inhibitors are the first line treatment with the rapid onset of effect, for all types of myasthenia gravis (ocular, generalized myasthenia gravis, seronegative or seropositive patients). "
01/01/2014 - "To evaluate the efficacy of acetylcholinesterase inhibitors in all forms of myasthenia gravis. "
01/01/2011 - "To evaluate the efficacy of acetylcholinesterase inhibitors in all forms of myasthenia gravis. "
01/01/2014 - "We did not find any large randomised or quasi-randomised trials of acetylcholinesterase inhibitors in generalised myasthenia gravis either for the first version of this review or this update. "
01/01/2011 - "We did not find any large randomised or quasi-randomised trials of acetylcholinesterase inhibitors in generalised myasthenia gravis. "
01/01/2002 - "Early studies indicate cholinesterase inhibitors can be beneficial for treating the hallucinations and behavior disturbances that afflict these patients and might also improve cognition."
06/01/2011 - "Cholinesterase inhibitors as a drug class have been shown to have beneficial effects on cognition in DLB and PDD, and may help to alleviate some psychiatric symptoms, such as apathy, anxiety, hallucinations, and delusions. "
11/01/2002 - "The cholinesterase inhibitors have shown to be useful in the treatment of hallucinations, anxiety and apathy."
07/01/2006 - "Cholinergic deficits are associated with visual hallucinations, and cholinesterase inhibitors often result in resolution of hallucinations, improved cognition, and decreased behavioral disturbances."
01/01/2015 - "Musical hallucinations treated with acetylcholinesterase inhibitors."
01/01/2007 - "The effects of potential mediators and confounders (demographic factors, neuropsychiatric symptoms, cognitive severity and cholinesterase inhibitors) were also examined. "
06/01/2005 - "Cholinesterase inhibitors have a moderate effect against cognitive symptoms. "
01/01/1998 - "Clinical pharmacologic approaches toward improvement of cognitive symptoms are discussed, with an emphasis on cholinergic approaches, since they currently appear most promising and since several cholinesterase inhibitors may soon be available for prescribing. "
07/01/2007 - "Acetylcholinesterase inhibitors (AChEIs) are effective in the treatment of cognitive symptoms in Alzheimer's disease (AD). "
11/01/2002 - "Anticholinesterases are known to be effective against cognitive and non-cognitive symptoms of Alzheimer's disease (AD) but their effect on the personality changes in the disease is not known. "
|5.||Acetylcholine (Acetylcholine Chloride)
|8.||Ginkgo biloba extract 761 (Rokan)
|10.||Neostigmine (Neostigmine Bromide)
|2.||Activities of Daily Living (ADL)
|3.||Drug Therapy (Chemotherapy)